JP6447991B2 - 花粉症減感作療法の治療効果を予測する方法及び診断薬 - Google Patents

花粉症減感作療法の治療効果を予測する方法及び診断薬 Download PDF

Info

Publication number
JP6447991B2
JP6447991B2 JP2014174499A JP2014174499A JP6447991B2 JP 6447991 B2 JP6447991 B2 JP 6447991B2 JP 2014174499 A JP2014174499 A JP 2014174499A JP 2014174499 A JP2014174499 A JP 2014174499A JP 6447991 B2 JP6447991 B2 JP 6447991B2
Authority
JP
Japan
Prior art keywords
gene
nucleic acid
desensitization therapy
cfh
osr2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2014174499A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016049025A5 (enExample
JP2016049025A (ja
Inventor
美孝 岡本
美孝 岡本
大樹 櫻井
大樹 櫻井
修二 米倉
修二 米倉
小原　收
收 小原
野中　謙
謙 野中
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chiba University NUC
Kazusa DNA Research Institute Foundation
Original Assignee
Chiba University NUC
Kazusa DNA Research Institute Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiba University NUC, Kazusa DNA Research Institute Foundation filed Critical Chiba University NUC
Priority to JP2014174499A priority Critical patent/JP6447991B2/ja
Publication of JP2016049025A publication Critical patent/JP2016049025A/ja
Publication of JP2016049025A5 publication Critical patent/JP2016049025A5/ja
Application granted granted Critical
Publication of JP6447991B2 publication Critical patent/JP6447991B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2014174499A 2014-08-28 2014-08-28 花粉症減感作療法の治療効果を予測する方法及び診断薬 Active JP6447991B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014174499A JP6447991B2 (ja) 2014-08-28 2014-08-28 花粉症減感作療法の治療効果を予測する方法及び診断薬

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014174499A JP6447991B2 (ja) 2014-08-28 2014-08-28 花粉症減感作療法の治療効果を予測する方法及び診断薬

Publications (3)

Publication Number Publication Date
JP2016049025A JP2016049025A (ja) 2016-04-11
JP2016049025A5 JP2016049025A5 (enExample) 2017-08-03
JP6447991B2 true JP6447991B2 (ja) 2019-01-09

Family

ID=55657080

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014174499A Active JP6447991B2 (ja) 2014-08-28 2014-08-28 花粉症減感作療法の治療効果を予測する方法及び診断薬

Country Status (1)

Country Link
JP (1) JP6447991B2 (enExample)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5858418B2 (ja) * 2011-03-30 2016-02-10 国立大学法人 千葉大学 花粉症ワクチンの治療効果を予測するバイオマーカー

Also Published As

Publication number Publication date
JP2016049025A (ja) 2016-04-11

Similar Documents

Publication Publication Date Title
US11579140B2 (en) Methods related to bronchial premalignant lesion severity and progression
Bremner et al. Kinetics of the cellular and transcriptomic response to Eimeria maxima in relatively resistant and susceptible chicken lines
CA2889087C (en) Diagnostic method for predicting response to tnf.alpha. inhibitor
US8586044B2 (en) Treatment of chronic pelvic pain syndrome
Shilovskiy et al. Modern view of neutrophilic asthma molecular mechanisms and therapy
US20200109453A1 (en) Methods of characterizing and treating hidradenitis suppurativa
Maeda et al. Expression of CC chemokine receptor 4 (CCR4) mRNA in canine atopic skin lesion
US20250268952A1 (en) Composition for preventing or treating deterioration in brain function or maintaining or improving brain function
CN101528947A (zh) 通过基因表达分析进行研究、判定或评价的方法
WO2011051402A1 (en) New biomarkers for determining allergy status
Katayanagi et al. Alternative gene expression by TOLLIP variant is associated with lung function in chronic hypersensitivity pneumonitis
CN118979104A (zh) 脓毒症相关疾病早期诊断标志物及其用途
WO2023076740A1 (en) Non-invasive direct transcriptomic profiling using stool samples for diagnosis of gastrointestinal diseases
JP6447991B2 (ja) 花粉症減感作療法の治療効果を予測する方法及び診断薬
EP3379934B1 (en) Methods and compositions for identifying subjects at risk for checkpoint blockade therapy associated colitis
KR20190133454A (ko) 질환의 진단용 조성물
CN115684594B (zh) Trem-2在制备多发性硬化症的治疗药物和/或诊断试剂中的应用
JP5858418B2 (ja) 花粉症ワクチンの治療効果を予測するバイオマーカー
Kim et al. Nypa fruticans Wurmb extract recovered compromised immune status induced by forced swimming in a mouse model
Arshad et al. Developments in the field of allergy in 2011 through the eyes of Clinical and Experimental Allergy
CN111549114A (zh) 心力衰竭的生物标志物及其应用
Mahittikorn et al. Toxoplasma gondii: Simple duplex RT-PCR assay for detecting SAG1 and BAG1 genes during stage conversion in immunosuppressed mice
CN115103918A (zh) 自闭症谱系障碍的检测和治疗
Liu et al. Reversing Immunosenescence with Senolytics to Enhance Tumor Immunotherapy
JP5264239B2 (ja) スギ花粉症検査を補助する方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170626

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170728

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20170728

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180508

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180621

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180904

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181003

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20181106

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20181127

R150 Certificate of patent or registration of utility model

Ref document number: 6447991

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250